Suppr超能文献

阿霉素肾病大鼠肾小球乙酰肝素酶表达的诱导受活性氧和肾素-血管紧张素系统调控。

Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.

作者信息

Kramer Andrea, van den Hoven Mabel, Rops Angelique, Wijnhoven Tessa, van den Heuvel Lambert, Lensen Joost, van Kuppevelt Toin, van Goor Harry, van der Vlag Johan, Navis Gerjan, Berden Jo H M

机构信息

Division of Nephrology (464), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

出版信息

J Am Soc Nephrol. 2006 Sep;17(9):2513-20. doi: 10.1681/ASN.2006020184. Epub 2006 Aug 9.

Abstract

Heparan sulfate (HS) in the glomerular basement membrane (GBM) is important for regulation of the charge-dependent permeability. Heparanase has been implicated in HS degradation in several proteinuric diseases. This study analyzed the role of heparanase in HS degradation in Adriamycin nephropathy (AN), a model of chronic proteinuria-induced renal damage. Expression of heparanase, HS, and the core protein of agrin (to which HS is attached) was determined on kidney sections from rats with AN in different experiments. First, expression was examined in a model of unilateral AN in a time-course study at 6-wk intervals until week 30. Second, rats were treated with the hydroxyl radical scavenger dimethylthiourea (DMTU) during bilateral AN induction. Finally, 6 wk after AN induction, rats were treated with angiotensin II receptor type 1 antagonist (AT1A) or vehicle for 2 wk. Heparanase expression was increased in glomeruli of rats with AN, which correlated with HS reduction at all time points and in all experiments. Treatment with DMTU prevented the increased heparanase expression, the loss of GBM HS, and reduced albuminuria. Finally, treatment of established proteinuria with AT1A significantly reduced heparanase expression and restored glomerular HS. In conclusion, an association between heparanase expression and reduction of glomerular HS in AN was observed. The effects of DMTU suggest a role for reactive oxygen species in upregulation of heparanase. Antiproteinuric treatment by AT1A decreased heparanase expression and restored HS expression. These results suggest involvement of radicals and angiotensin II in the modulation of GBM permeability through HS and heparanase expression.

摘要

肾小球基底膜(GBM)中的硫酸乙酰肝素(HS)对于调节电荷依赖性通透性至关重要。在几种蛋白尿性疾病中,乙酰肝素酶与HS降解有关。本研究分析了乙酰肝素酶在阿霉素肾病(AN)(一种慢性蛋白尿诱导的肾损伤模型)中HS降解中的作用。在不同实验中,测定了AN大鼠肾切片中乙酰肝素酶、HS和集聚蛋白核心蛋白(HS与之结合)的表达。首先,在单侧AN模型中进行时间进程研究,每隔6周检测一次表达情况,直至第30周。其次,在双侧AN诱导期间,用羟基自由基清除剂二甲基硫脲(DMTU)处理大鼠。最后,在AN诱导6周后,用1型血管紧张素II受体拮抗剂(AT1A)或赋形剂处理大鼠2周。AN大鼠肾小球中乙酰肝素酶表达增加,这与所有时间点和所有实验中HS的减少相关。用DMTU处理可防止乙酰肝素酶表达增加、GBM HS丢失并减少蛋白尿。最后,用AT1A治疗已建立的蛋白尿可显著降低乙酰肝素酶表达并恢复肾小球HS。总之,观察到AN中乙酰肝素酶表达与肾小球HS减少之间存在关联。DMTU的作用表明活性氧在乙酰肝素酶上调中起作用。AT1A的抗蛋白尿治疗降低了乙酰肝素酶表达并恢复了HS表达。这些结果表明自由基和血管紧张素II通过HS和乙酰肝素酶表达参与了GBM通透性的调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验